Statement Of Cash Flows [Abstract]

Alligator Bioscience - Filing #679585

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
237 021 SEK
181 588 SEK
Adjustments for decrease (increase) in trade and other receivables
13 267 SEK
5 859 SEK
Adjustments for increase (decrease) in trade and other payables
34 468 SEK
14 840 SEK
Income taxes paid, classified as operating activities
- SEK
- SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of options
- SEK
426,000 SEK
Proceeds from exercise of warrants
440,000 SEK
- SEK
Payments for share issue costs
24 142 SEK
343,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.